| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c190c99174dfe46deef72ae3ad792590 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 |
| filingDate |
2010-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79a9274c61cad2114830e64f04d5e4bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dfdcb8a55adbf5daa56b2615fdce7cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f8ad15527f2b0d6be32fab85ff284b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2600f56ede4460aa065ac1555273e600
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce92ea0a800322848dc9b1db05ecad5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa93e9486779bef628cfab2894e0c06a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6f59c0f856482b317f956d20619d52d |
| publicationDate |
2016-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2010331291-B2 |
| titleOfInvention |
Method for diagnosing malignant tumor |
| abstract |
Provided are a method for determining the presence of a malignant tumor or the severity thereof, selecting a therapeutic method therefor or evaluating the effect of said therapeutic method, or estimating the recurrence risk of said malignant tumor or the presence or absence of the recurrence of the same, and a diagnostic kit for the same purposes. The method for determining the presence of a malignant tumor or the severity thereof, selecting a therapeutic method therefor or evaluating the effect of said therapeutic method, or estimating the recurrence risk of said malignant tumor or the presence or absence of the recurrence of the same is characterized by comprising: a step (1) for measuring the concentration and/or quantity of soluble LR11 in a sample originating in a subject; and a step (2) for comparing the measurement data with the measurement data of soluble LR11 obtained from a group of normal subjects. |
| priorityDate |
2009-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |